-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OZOazrpeaJ8B67zHyiWaFfT8EOH68/wEDlkohf3T4eU/MUs84s3jjPM5pmkGywoC v93DijSpL2UmtLL2D6fJ8g== 0000905718-97-000351.txt : 19970827 0000905718-97-000351.hdr.sgml : 19970827 ACCESSION NUMBER: 0000905718-97-000351 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970826 SROS: NYSE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ISOMEDIX INC CENTRAL INDEX KEY: 0000719522 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 221986189 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-34751 FILM NUMBER: 97670000 BUSINESS ADDRESS: STREET 1: 11 APOLLO DR CITY: WHIPPANY STATE: NJ ZIP: 07981 BUSINESS PHONE: 2018874700 MAIL ADDRESS: STREET 1: 11 APOLLO DR CITY: WHIPPANY STATE: NJ ZIP: 07981 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ROTH MICHAEL CENTRAL INDEX KEY: 0001010207 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 10556 N PORT WASHINGTON RD CITY: MEQUON STATE: WI ZIP: 53092 BUSINESS PHONE: 4142411810 MAIL ADDRESS: STREET 1: 10556 N PORT WASHINGTON RD CITY: MEQUON STATE: WI ZIP: 53092 SC 13D 1 SCHED 13 D FOR ISOMEDIX INC SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE l3D Under the Securities Exchange Act of 1934 (Amendment No. __)* Isomedix Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $.01 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 4648901027 - -------------------------------------------------------------------------------- (CUSIP Number) with a copy to: Krista L. Ward George J. Mazin Stark Investments Lowenstein, Sandler, Kohl, 1500 West Market Street Fisher & Boylan, P.A. Mequon, WI 53092 65 Livingston Avenue (414) 241-1810 Roseland, New Jersey 07068 (201) 992-8700 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 15, 1997 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule l3G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ]. Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule l3d-1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- CUSIP NO. 4648901027 - -------------------------------------------------------------------------------- 1) Names of Reporting Persons (S.S. or I.R.S. Identification Nos. of Above Persons): Michael A. Roth and Brian J. Stark (filing as joint filers pursuant to Rule 13(d)1(f)(1)) - -------------------------------------------------------------------------------- 2) Check the Appropriate Box if a Member of a Group (See Instructions): (a) Not (b) Applicable - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Source of Funds (See Instructions):WC - -------------------------------------------------------------------------------- 5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e): Not Applicable - -------------------------------------------------------------------------------- 6) Citizenship or Place of Organization: Wisconsin - -------------------------------------------------------------------------------- Number of 7) Sole Voting Power: 0 --------------------------------------- Shares Beneficially 8) Shared Voting Power: 365,000* -------------------------------------- Owned by Each Reporting 9) Sole Dispositive Power: 0 --------------------------------------- Person With: 10) Shared Dispositive Power: 365,000* --------------------------------------- - -------------------------------------------------------------------------------- 11) Aggregate Amount Beneficially Owned by Each Reporting Person: 365,000* - -------------------------------------------------------------------------------- 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): Not Applicable - -------------------------------------------------------------------------------- 13) Percent of Class Represented by Amount in Row (11): 5.65%* - -------------------------------------------------------------------------------- 14) Type of Reporting Person (See Instructions): IN - -------------------------------------------------------------------------------- * Includes 182,500 shares of the Issuer's common stock beneficially owned by Reliant Trading and 182,500 shares of the Issuer's common stock beneficially owned by Shepherd Trading Limited. See Item 2 and Item 5 for additional details. Item 1: Security and Issuer: This statement relates to the Common Stock, par value $.01 per share, of Isomedix Inc. ("Shares"). The issuer has principal executive offices located at 11 Apollo Drive, Whippany, New Jersey 07981. Item 2: Identity and Background 1. a) Name: Brian J. Stark b) Residence or Business Address: 1500 West Market Street Mequon, WI 53092 c) Occupation: Investment Fund Manager Staro Asset Management, L.L.C., Stark & Roth, Inc., Staro Partners 1500 West Market Street Mequon, WI 53092 d) Convictions: none e) Civil Proceedings: none f) Citizenship: United States 2. a) Name: Michael A. Roth b) Residence or Business Address: 1500 West Market Street Mequon, WI 53092 c) Occupation: Investment Fund Manager Staro Asset Management, L.L.C., Stark & Roth, Inc., Staro Partners 1500 West Market Street Mequon, WI 53092 d) Convictions: none e) Civil Proceedings: none f) Citizenship: United States 3. a) Name: Staro Partners b) State of Organization: Wisconsin c) Principal Business: Securities Trading d) Address of principal business: 1500 West Market Street Mequon, WI 53092 e) Address of Principal Office: same f) Convictions: none g) Civil proceedings: none 4. a) Name: Reliant Trading b) State of Organization: Wisconsin c) Principal Business: Securities Trading d) Address of principal business: 1500 West Market Street Mequon, WI 53092 e) Address of Principal Office: same f) Convictions: none g) Civil proceedings: none 5. a) Name: Shepherd Trading Limited b) State of Organization: British Virgin Islands c) Principal Business: Securities Trading Address of principal business: c/o International Fund Administration, Ltd. 48 Par-La Ville Road, Suite 464 Hamilton, HM 11 Bermuda d) Address of Principal Office: same e) Convictions: none f) Civil proceedings: none Item 3: Source and Amount of Funds or Other Consideration All funds used by Reliant Trading to purchase Shares acquired by Reliant Trading were obtained from the capital contributed by the limited partners of Stark Investments, L.P. and general margin financing from brokers. The amount of funds used in making the purchases was $3,700,330. The funds used by Shepherd Trading Limited to purchase the Shares acquired by Shepherd Trading Limited were obtained from the capital contributed by the shareholders of Shepherd Fund Limited. The amount of funds used in making the purchases was $3,700,330. Item 4: Purpose of Transaction The acquisition of the Shares by Reliant Trading and by Shepherd Trading Limited are solely for investment purposes. Further acquisitions, sales or short sales of securities of the Issuer may be made for investment purposes, however, neither reporting person has present plans or intentions which relate to or would result in any of the transactions required to be described in Item 4 of Schedule 13D. Item 5: Interest in Securities of the Issuer Based upon the information contained in Isomedix Inc.'s 10 Q for the fiscal quarter ending June 30, 1997, there were issued and outstanding 6,459,098 Shares. Messrs. Stark and Roth beneficially own 365,000 Shares or 5.65% of the Shares. 182,500 of such Shares are held by Reliant Trading. Messrs. Stark and Roth have shares power to vote or direct the vote and shared power to dispose or direct the disposition of the 182,500 Shares by virtue of their position as members of Staro Asset Management, L.L.C., the managing partner of Reliant Trading. 182,500 Shares are held by Shepherd Trading Limited. Messrs. Stark and Roth have shares power to vote or direct the vote and shared power to dispose or direct the disposition of the 182,500 Shares by virtue of their position as investment manager of Shepherd Trading Limited. The following Table details the transactions by Reliant Trading and Shepherd Trading Limited in the Common Stock of Isomedix Inc. during the past 60 days: Shepherd Trading Limited Date Quantity Price Transaction Type 8/15/97 150,000 $20.25 Open Mkt. Purchase 8/14/97 12,500 20.25 Open Mkt. Purchase 8/13/97 20,000 20.226 Open Mkt. Purchase Reliant Trading Date Quantity Price Transaction Type 8/15/97 150,000 $20.25 Open Mkt. Purchase 8/14/97 12,500 20.25 Open Mkt. Purchase 8/13/97 20,000 20.226 Open Mkt. Purchase No other entity controlled by the reporting persons has traded Isomedix Inc. Common Stock within the past 60 days. Item 6: Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. See Item 2. Item 7: Material to be filed as exhibits. Exhibit 1: Agreement as to joint filing. EXHIBIT 1 AGREEMENT AS TO JOINT FILING Dated August 26, 1997 The undersigned hereby agree that the Schedule 13D with respect to Isomedix Inc. dated as of the date hereof is filed on behalf of each of the undersigned jointly pursuant to Rule 13d-1(f)(1). /s/Brian J. Stark -------------------- Brian J. Stark /s/Michael A. Roth -------------------- Michael A. Roth SIGNATURE After reasonable inquiry and to the best of the undersigned's knowledge and belief, the undersigned hereby certifies that the information set forth in this statement is true, complete and correct. August 26, 1997 /s/Brian J. Stark --------------------- Brian J. Stark /s/ Michael A. Roth --------------------- Michael A. Roth ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001). -----END PRIVACY-ENHANCED MESSAGE-----